Characterization of Bet v 1-related allergens from kiwifruit relevant for patients with combined kiwifruit and birch pollen allergy

被引:49
|
作者
Oberhuber, Christina [2 ]
Bulley, Sean M. [3 ]
Ballmer-Weber, Barbara K. [4 ]
Bublin, Merima [1 ]
Gaier, Sonja [1 ]
DeWitt, Asa Marknell [5 ]
Briza, Peter [6 ]
Hofstetter, Gerlinde [1 ]
Lidholm, Jonas [5 ]
Vieths, Stefan [7 ]
Hoffmann-Sommergruber, Karin [1 ]
机构
[1] Med Univ Vienna, Dept Pathophysiol, A-1090 Vienna, Austria
[2] Biomay AG, Vienna, Austria
[3] Hort & Food Res Inst New Zealand Ltd, Auckland, New Zealand
[4] Univ Zurich Hosp, Dept Dermatol, Allergy Unit, CH-8091 Zurich, Switzerland
[5] Phadia AB, Uppsala, Sweden
[6] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria
[7] Paul Ehrlich Inst, D-6070 Langen, Germany
关键词
Bet v 1; Food allergy; Kiwifruit; Pollen allergy; Recombinant allergen;
D O I
10.1002/mnfr.200800146
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Allergy to kiwifruit appears to have become more common in Europe and elsewhere during the past several years. Seven allergens have been identified from kiwifruit so far, with actinidin, kiwellin and the thaumatin-like protein as the most relevant ones. In contrast to other fruits, no Bet v 1 homologues were characterized from kiwifruit so far. We cloned, purified, and characterized recombinant Bet v 1-homologous allergens from green (Actinidia deliciosa, Act d 8) and gold (Actinidia chinensis, Act c 8) kiwifruit, and confirmed the presence of its natural counterpart by inhibition assays. Well-characterized recombinant Act d 8 and Act c 8 were recognized by birch pollen/kiwifruit (confirmed by double-blind placebo-controlled food challenge) allergic patients in IgE immunoblots and ELISA experiments. The present data point out that Bet v 1 homologues are allergens in kiwifruit and of relevance for patients sensitized to tree pollen and kiwifruit, and might have been neglected so far due to low abundance in the conventional extracts used for diagnosis.
引用
收藏
页码:S230 / S240
页数:11
相关论文
共 50 条
  • [41] Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccination
    Vrtala, Susanne
    Fohr, Monika
    Campana, Raffaela
    Baumgartner, Christian
    Valent, Peter
    Valenta, Rudolf
    VACCINE, 2011, 29 (11) : 2140 - 2148
  • [42] Subcutaneous Immunotherapy with Mannan-conjugated Birch Pollen Allergoids significantly increases bet v1-specific Immunoglobulins in Birch Pollen Allergy Sufferers
    Decker, L.
    Xenofontos, E.
    Raskopf, E.
    Wahrhusen, N.
    England, L.
    Katzke, N.
    Acikel, C.
    Casanovas, M.
    Subiza, J. L.
    Cuevas, M.
    Allekotte, S.
    Moesges, R.
    ALLERGOLOGIE, 2023, 46 (08) : 519 - 519
  • [43] Skin response to recombinant birch pollen allergen (Bet v1a) in allergic patients during and out of the birch pollen season
    Brzezinska-Pawlowska, O.
    Lupinek, C.
    Piechota-Polanczyk, A.
    Kurowski, M.
    Jablonska, A.
    Stolz, F.
    Kopp, S.
    Neubauer, A.
    Kiss, R.
    Valenta, R.
    Kowalski, M. L.
    ALLERGY, 2015, 70 : 173 - 173
  • [44] IgG-Epitope Mapping of Birch-Pollen Bet v 1 Allergen in Allergic and Treated Patients for the Design of Hypoallergenic Immunotherapy Allergens
    Paolucci, M.
    Sosic, L.
    Streuli, A.
    Melillo, D.
    Sousa-Augusto, G.
    Lang, C. C.
    Duda, A.
    Jiang, T.
    Campana, R.
    Bachmann, M.
    Schmid-Grendelmeier, P.
    Eyer, K.
    Kundig, T. M.
    Johansen, P.
    SWISS MEDICAL WEEKLY, 2024, 154 : 14S - 14S
  • [45] Bet v 1 proteins, the major birch pollen allergens and members of a family of conserved pathogenesis-related proteins, show ribonuclease activity in vitro
    Swoboda, I
    HoffmannSommergruber, K
    ORiordain, G
    Scheiner, O
    HeberleBors, E
    Vicente, O
    PHYSIOLOGIA PLANTARUM, 1996, 96 (03) : 433 - 438
  • [46] Occupational Rhinoconjunctivitis and Asthma Caused by Chicory and Oral Allergy Syndrome Associated With Bet v 1-Related Protein
    Pirson, F.
    Detry, B.
    Pilette, C.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2009, 19 (04) : 306 - 310
  • [47] Naturally occurring hypoallergenic Bet v 1 isoforms fail to induce IgE responses in individuals with birch pollen allergy
    Wagner, Stefan
    Radauer, Christian
    Bublin, Merima
    Mann-Sommergruber, Karin Hoff
    Kopp, Tamara
    Greisenegger, Elli K.
    Vogel, Lothar
    Vieths, Stefan
    Scheiner, Otto
    Breiteneder, Heimo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (01) : 246 - 252
  • [48] Oligomerization and tyrosine nitration enhance the allergenic potential of the birch and grass pollen allergens Bet v 1 and Phl p 5
    Froehlich-Nowoisky, Janine
    Bothen, Nadine
    Backes, Anna T.
    Weller, Michael G.
    Poeschl, Ulrich
    FRONTIERS IN ALLERGY, 2023, 4
  • [49] Characterization of epitope specificities of reference antibodies used for the quantification of the birch pollen allergen Bet v 1
    Brier, S.
    Le Mignon, M.
    Jain, K.
    Lebrun, C.
    Peurois, F.
    Kellenberger, C.
    Bordas-Le Floch, V.
    Mascarell, L.
    Nony, E.
    Moingeon, P.
    ALLERGY, 2018, 73 (05) : 1032 - 1040
  • [50] Bet v 1 from birch pollen is a hypoallergen with vitamin D3 in the pocket
    Hufnagl, Karin
    Kromp, Livia
    Bianchini, Rodolfo
    Afify, Sheriene Moussa
    Wiederstein, Markus
    Redegeld, Frank A.
    Zuvalova, Iveta
    Dvorak, Zdenek
    Hofstetter, Gerlinde
    Roth-Walter, Franziska
    Pacios, Luis F.
    Jensen-Jarolim, Erika
    ALLERGY, 2021, 76 (12) : 3801 - 3804